IP Library Granted Patent US 7,785,798
Granted Patent B2
US 7,785,798 · App. 12/553,225 · Granted Aug 31, 2010

Methods for prenatal diagnosis of chromosomal abnormalities

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,785,798
App. No.
12/553,225
Granted
Aug 31, 2010
Kind
B2
Abstract

Chromosomal abnormalities are responsible for a significant number of birth defects, including mental retardation. The present invention is related to methods for non-invasive and rapid, prenatal diagnosis of chromosomal abnormalities based on analysis of a maternal blood sample. The invention exploits the differences in DNA between the mother and fetus, for instance differences in their methylation states, as a means to enrich for fetal DNA in maternal plasma sample. The methods described herein can be used to detect chromosomal DNA deletions and duplications. In a preferred embodiment, the methods are used to diagnose chromosomal aneuploidy and related disorders, such as Down's and Turner's Syndrome.

Claims (7)

1. A method for enriching feta DNA in a maternal plasma sample, comprising digesting the DNA present in said sample with a methyl-sensitive enzyme that selectively and substantially completely digests maternal DNA to obtain a sample enriched for fetal nucleic acids.

2. The method of claim 1 , further comprising a nucleic acid amplification step, wherein after digestion fetal nucleic acid is amplified preferentially.

3. The method of claim 1 , wherein said methyl-sensitive enzyme digests only at nucleic acid recognition sites that are unmethylated.

4. The method of claim 1 , wherein said methyl-sensitive enzyme digests only at nucleic acid recognition sites that are methylated.

5. The method of claim 1 , wherein the DNA is isolated from the plasma sample before it is digested with a methyl-sensitive enzyme.

6. The method of claim 1 or 5 , further comprising a step of isolating the undigested fetal DNA after digesting the maternal DNA in said sample with a methyl-sensitive enzyme.

7. The method of claim 1 , wherein the step of digesting the DNA present in said sample is performed using two or more methyl-sensitive enzymes.